Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies (Q34366867)

1 August 2017

Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies (English)

1 reference

1 August 2017

1 reference

Shu-hua Xiao

1

1 reference

1 August 2017

27 August 2013

1 reference

1 August 2017

Parasitology Research

1 reference

1 August 2017

112

1 reference

1 August 2017

11

1 reference

1 August 2017

3723-3740

1 reference

https://scigraph.springernature.com/pub.10.1007/s00436-013-3559-0

1 August 2017

0 references

cites work

Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Chemotherapy of schistosomiasis: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

The immune-dependence of chemotherapy in experimental schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Miltefosine, a promising novel agent for schistosomiasis mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Schistosoma mansoni: schistosomicidal effect of mefloquine and primaquine in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Antischistosomal activities of mefloquine-related arylmethanols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Disposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Artemisinins and synthetic trioxolanes in the treatment of helminth infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Mefloquine--an aminoalcohol with promising antischistosomal properties in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immunocompetent NMRI mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Mefloquine interferes with glycolysis in schistosomula of Schistosoma mansoni via inhibition of enolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

A study of the activity of 2-(alkylamino)-1-phenyl-1-ethanethiosulfuric acids against infection by Schistosoma mansoni in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Antimalarials. 7. Bis(trifluoromethyl)-.alpha.-(2-piperidyl)-4-quinolinemethanols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Schistosoma mansoni: chemotherapy of infections of different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Identification of oxadiazoles as new drug leads for the control of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

The present status of malaria chemotherapy: mefloquine, a novel antimalarial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Identification of an antimalarial synthetic trioxolane drug development candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

The prophylactic effects of artemether against Schistosoma japonicum infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Histopathological alteration of juvenile Schistosoma japonicum in mice following treatment with single-dose mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Further observation on histopathological alterations of adult Schistosoma japonicum harbored in mice following treatment with mefloquine at a smaller single dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Research and development of antischistosomal drugs in the People's Republic of China a 60-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Transmission electron microscopic observation on ultrastructural alterations in Schistosoma japonicum caused by mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Effectiveness of mefloquine against Clonorchis sinensis in rats and Paragonimus westermani in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Confocal laser scanning microscopic observation on adult Schistosoma japonicum harbored in mice following treatment with single-dose mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Further studies on mefloquine and praziquantel alone or interaction of both drugs against Schistosoma japonicum in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Histopathological changes of juvenile Schistosoma japonicum harbored in mice treated orally with mefloquine at a smaller single dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3559-0

Progress in development of new antischistosomal drugs in recent years

21 January 2018

1 reference

12 December 2020

Tegumental alterations of adult Schistosoma japonicum harbored in mice treated with a single oral dose of mefloquine.

1 reference

12 December 2020

Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel.

1 reference

12 December 2020

Antimalarials in the treatment of schistosomiasis.

1 reference

12 December 2020

Relationship between the effects of praziquantel on mice and rabbits with different intensities of Schistosoma japonicum infection and humoral immunity levels of the host

1 reference

12 December 2020

Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits

1 reference

12 December 2020

Artemisinin-based combination therapies for uncomplicated malaria

1 reference

12 December 2020

Artemisinins for schistosomiasis and beyond.

1 reference

12 December 2020

The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response

1 reference

12 December 2020

Preliminary observation on the effect of mefloquine against egg granuloma formation in the liver of mice infected with Schistosoma japonicum

1 reference

12 December 2020

Studies on prophylactic effect of artesunate on schistosomiasis japonica

1 reference

12 December 2020

[Prophylactic activity of praziquantel in animals infected with Schistosoma japonicum]

1 reference

12 December 2020

Experimental studies on early treatment of schistosomal infection with artemether

1 reference

12 December 2020

[Studies on the efficacy of artemether in experimental schistosomiasis (author's transl)]

1 reference

12 December 2020

10.1007/S00436-013-3559-0

Identifiers

DOI

1 reference

PubMed ID

23979493

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

23979493